Back to the Top
Dear collegues,
I'm setting up a study in humans to investigate interaction for renal
excretion. The drug has affinity for both organic cation and anion
transport, no pgp known. What would be the best and most specific in
vivo interactant drugs for 1. the OAT (organic anion transporter) and
2. OCT (organic cation transporter)?
Best regards, Sandra Boom
Back to the Top
Hello Sandra Boom
Here is the list of in-vivo interactant drugs for OAT and OCT
1)OAT - Acetylesalicylate ,
Indomethacin,Bumetanide,Furosemide,Methotrexate,Valproate
2)OCT - Amiloride,Atropine,Cimetidine,Morphine,Procaine,Quinine as well
some cytostatic agents.
Thanks and Regards
Dr.Sajjad A. Desai
Back to the Top
The following message was posted to: PharmPK
Since you are proposing to conduct the study in humans, the safety
profile of the both the inhibitor compound and the drug of interest will
be important. The safety profile of probenecid (inhibitor of OAT) and
cimetidine (inhibitor of OCT) are well known. You mentioned that your
compound is not a P-gp substrate; however, is it a substrate for MRP? A
three-way crossover design would be ideal to separate out the relative
contributions of the transporters to the renal clearance of your
compound.
A detailed summary of renal drug transporters and substrate/inhibitor
compounds has recently been published:
Lee Wooin, Kim R. Transporters and renal drug elimination. Annu Rev
Pharmacol Toxicol. Online publication Aug 2003.
Paul Beringer, Pharm.D.
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)